Notice of Closed Meeting, 13121-13122 [2023-04239]
Download as PDF
<![CDATA[
13121
Federal Register / Vol. 88, No. 41 / Thursday, March 2, 2023 / Notices
EXHIBIT A.2—ESTIMATED ANNUALIZED COST BURDEN—Continued
Number of
respondents *
Form name
2. AHRQ Office Readiness Survey (cancer diagnostic process cohort only)
3. AHRQ Patient Safety Culture Surveys:
a. MOSOPS (both cohorts):
i. Physicians ....................................................................................
ii. Other Health Practitioners ...........................................................
b. Diagnostic Safety Supplement (cancer diagnostic process cohort
only):
i. Physicians ....................................................................................
ii. Other Health Practitioners ...........................................................
4. Participant Experience Survey (both cohorts) ...........................................
5. Semi-structured qualitative interviews (both cohorts) ...............................
6. Clinical Data Collection Form (cancer diagnostic process cohort only) ...
7. EHR data (AS cohort only) ........................................................................
Total ........................................................................................................
Average
hourly wage
rate **
Total burden
hours
Total
burden
cost
350
35
a 111.30
3,896
466
467
466
467
a 111.30
51,866
14,566
175
175
200
24
90
150
70
70
54
24
1,604
2,700
a 111.30
a 111.30
7,791
2,183
6,010
2,671
178,525
300,510
3,497
5,917
........................
576,922
b 31.19
b 31.19
a 111.30
a 111.30
a 111.30
** Annualized number of respondents is based on maximum practices recruited and 75% response rate for forms 1 and 4, 50% response rate
for forms 2, 3a and 3b, and 90% response rate for forms 5–7.
** National Compensation Survey: Occupational wages in the United States May 2021 ‘‘U.S. Department of Labor, Bureau of Labor Statistics’’:
https://www.bls.gov/oes/current/oes_stru.htm#29-0000.
a Based on the mean wages for 29–1069 Physicians and Surgeons, All Other.
b Based on the mean wages for 29–9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare Practitioners and Technical
Workers, All Other.
Request for Comments
ddrumheller on DSK120RN23PROD with NOTICES1
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: February 23, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–04220 Filed 3–1–23; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
18:21 Mar 01, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
GH23–003, Conducting Public Health
Research with Universities in Thailand.
Date: April 12, 2023.
Time: 9 a.m.–2:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Hylan Shoob, Ph.D., Scientific Review
Officer, Center for Global Health, CDC,
1600 Clifton Road NE, Mailstop H21–9,
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Atlanta, Georgia 30329–4027;
Telephone: (404) 639–4796; Email:
HShoob@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–04241 Filed 3–1–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
E:\FR\FM\02MRN1.SGM
02MRN1
13122
Federal Register / Vol. 88, No. 41 / Thursday, March 2, 2023 / Notices
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
GH19–005, Advancing Public Health
Research in Bangladesh; and GH21–003,
Advancing Public Health Research in
Kenya.
Date: April 13, 2023.
Time: 9 a.m.–2:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Hylan Shoob, Ph.D., Scientific Review
Officer, Center for Global Health, CDC,
1600 Clifton Road NE, Mailstop H21–9,
Atlanta, Georgia 30329–4027;
Telephone: (404) 639–4796; Email:
HShoob@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–04239 Filed 3–1–23; 8:45 am]
BILLING CODE 4163–18–P
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
GH21–001, Conducting Public Health
Research in Thailand: Technical
collaboration with the Ministry of
Public Health (MOPH) in the Kingdom
of Thailand; and GH23–001, Enhancing
Capacity for Strategic and Applied
Research Activities in Support of
Control and Elimination of Neglected
Tropical Diseases.
Date: April 11, 2023.
Time: 9 a.m.–2:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Hylan Shoob, Ph.D., Scientific Review
Officer, Center for Global Health, CDC,
1600 Clifton Road NE, Mailstop H21–9,
Atlanta, Georgia 30329–4027;
Telephone: (404) 639–4796; Email:
HShoob@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–04240 Filed 3–1–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
ddrumheller on DSK120RN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
VerDate Sep<11>2014
18:21 Mar 01, 2023
Jkt 259001
Board of Scientific Counselors, Center
for Preparedness and Response
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Board of Scientific Counselors, Center
for Preparedness and Response (BSC,
CPR). This is a hybrid meeting,
SUMMARY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
accessible both in person and virtually.
It is open to the public and limited only
by the space available and the number
of internet conference accesses
available. Time will be available for
public comment.
DATES: The meeting will be held on
March 30, 2023, from 9 a.m. to 3 p.m.,
EDT.
ADDRESSES: Centers for Disease Control
and Prevention, Building 19,
Auditorium B3, 1600 Clifton Road NE,
Atlanta, Georgia 30329–4027. The
conference room will have seating for
approximately 40 people.
Please note that the meeting location
is a federal facility and in-person access
is limited to United States citizens
unless prior authorizations, taking up to
30 to 60 days, have been made. Visitors
must follow all directions for access to
CDC facilities. Directions for visitors to
CDC, including safety requirements
related to COVID–19, are available at
https://www.cdc.gov/screening/
visitors.html.
If you wish to attend in person, please
submit a request by email to Ms. Dometa
Ouisley at DOuisley@cdc.gov at least 5
business days in advance of the
meeting.
If you wish to attend the meeting
virtually, please register by accessing
the link at: https://cdc.zoomgov.com/
webinar/register/WN_SFaFlNxBQtK3_
Sux-5KfJw. Instructions to access the
Zoom virtual meeting will be provided
in the link following registration.
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Public Health Analyst,
Office of Science and Public Health
Practice, Office of Readiness and
Response, CDC, 1600 Clifton Road NE,
Mailstop H21–6, Atlanta, Georgia
30329–4027; Telephone: (404) 639–
7450; Email: DOuisley@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board of Scientific
Counselors, Center for Preparedness and
Response (BSC, CPR) is charged with
providing advice and guidance to the
Secretary, HHS; the Assistant Secretary
for Health; the Director, CDC; and the
Director, CPR, concerning strategies and
goals for the programs and research
within the agency and CPR; monitoring
the overall strategic direction and focus
of the CPR Divisions and Offices; and
administration and oversight of peer
review for CPR scientific programs. For
additional information about the Board,
please visit: https://www.cdc.gov/cpr/
bsc/index.htm.
Matters To Be Considered: The agenda
will include discussion on: (1)
Organizational Update; (2) Office of
Policy, Planning, and Evaluation
Update; (3) CDCReady Responder
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 88, Number 41 (Thursday, March 2, 2023)]
[Notices]
[Pages 13121-13122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04239]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could
[[Page 13122]]
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)- GH19-005, Advancing Public Health
Research in Bangladesh; and GH21-003, Advancing Public Health Research
in Kenya.
Date: April 13, 2023.
Time: 9 a.m.-2:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Hylan Shoob, Ph.D., Scientific
Review Officer, Center for Global Health, CDC, 1600 Clifton Road NE,
Mailstop H21-9, Atlanta, Georgia 30329-4027; Telephone: (404) 639-4796;
Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04239 Filed 3-1-23; 8:45 am]
BILLING CODE 4163-18-P
